ASC-H
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL (NCT03911076) | PapiVax Biotech, Inc. | 2019-05-22 |
Track ASC-H automatically
Every clearance here is in the API, with alerts when new ones post.